Intratumoral Treatment with 5-Androstene-3β, 17α-Diol Reduces Tumor Size and Lung Metastasis in a Triple-Negative Experimental Model of Breast Cancer

Breast cancer treatment failure is related to low response rates, high costs, and long-term toxicities. Thus, it is necessary to find less toxic, cheaper, and more effective treatments. In situ administration ensures drug delivery to tumor cells and decreases systemic toxic effects. The androstene-3...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz Manzano, Rocío Alejandra, Nava-Castro, Karen Elizabeth, Palacios-Arreola, Margarita Isabel, Hernández-Cervantes, Rosalía, Del Río-Araiza, Víctor Hugo, Segovia-Mendoza, Mariana, Pérez-Torres, Armando, Girón-Pérez, Manuel Iván, Morales-Montor, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570136/
https://www.ncbi.nlm.nih.gov/pubmed/36233245
http://dx.doi.org/10.3390/ijms231911944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570136/
https://www.ncbi.nlm.nih.gov/pubmed/36233245
http://dx.doi.org/10.3390/ijms231911944

Ejemplares similares